Navigation Links
Valence Health Selected by Cleveland Clinic to Support Clinical Integration Program
Date:1/14/2011

CHICAGO, Jan. 14, 2011  /PRNewswire/ -- The Cleveland Clinic and Valence Health announced today that they will partner to support the Clinic's effort to become a clinically integrated network.  This new network, the Quality Alliance, will bring together the Cleveland Clinic Hospitals, physicians, and more than 1,000 private practitioners in the community.

The Cleveland Clinic, through its Community Physician Partnership (CPP), recognized the need to pursue Clinical Integration as a contracting vehicle and quality of care strategy, creating substantial interdependence among its participating providers.  After an extensive search for the right solution, CPP leadership selected Valence based on their unique ability to aggregate health care data from physicians, hospitals, and other providers. "We were looking for a partner who could provide the tools and support to meet our goals of improving quality and standardizing patient care," states Michael McMillan, Executive Director of Cleveland Clinic Market and Network Services.

Valence's clinical integration solution includes assistance with physician integration strategies, data collection and analysis, performance reporting, and point-of-care tools to support improved quality and efficiencies.

About Valence Health

Valence Health was founded in March 1996 with a vision of providing management support to providers and provider initiatives such as IPAS, PHOs and integrated delivery systems. Today, Valence provides outsourced administrative management services to health plans and clinical integration solutions through data analytics and other custom tools to support provider organizations in their desire to manage care as effectively and efficiently as possible. For more information about Valence Health's Clinical Integration capabilities and solutions, contact Lori Fox Ward, VP of Clinical Integration, at 312.277.6304 or visit www.valencehealth.com.

About Cleveland Clinic

The Cleveland Clinic Community Physician Partnership (CPP) is a network of physicians, hospitals, health centers and other providers affiliated with the Cleveland Clinic Health System. They serve the patient population in a seven-country service area of Northeast Ohio. The CPP provider organization is comprised of the Cleveland Clinic main campus; nine regional hospitals; approximately 2,000 physicians and 800 mid-level providers employed by the Cleveland Clinic; and approximately 1,250 independent community physicians in private practice.


'/>"/>
SOURCE Valence Health
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. MonoSol Rx Completes Thin Film Ondansetron Pilot Bioequivalence Study
2. New Survey Suggests Cultural Ambivalence to Allergies Leaves Many Suffering Needlessly
3. ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study
4. Insmed Announces First Human Bioequivalence Data for a Follow-on Biologic by a U.S. Company
5. Genomas Clinical Study Finds Increased Prevalence of Drug Metabolism Deficiencies in Patients With Serious Psychotropic Side Effects
6. MannKind Reports Successful Completion of Device Bioequivalence Trial
7. ADVENTRX Completes Patient Enrollment in ANX-514 Bioequivalence Study
8. ViroPharma Submits Comments on Vancocin(R) Draft Bioequivalence Guidance
9. ADVENTRX Announces Results From ANX-514 Bioequivalence Study
10. The Hepatitis C Virus Drug Market Will Nearly Triple by 2014 but, Thereafter, the Market Will Decline Substantially Through 2019 Due to Decreasing Disease Prevalence and the High Efficacy of New Treatments
11. The Hepatitis C Virus Drug Market Will More Than Triple by 2014 but, Thereafter, the Market Will Decline Substantially Through 2019 Due to Decreasing Disease Prevalence and the High Efficacy of New Treatments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... April 19, 2017  Novartis today announced the ... Heart, Lung, and Blood Institute (NHLBI) of the ... of patients with treatment-naïve severe aplastic anemia (SAA) ... with eltrombopag at the initiation of and concurrently ... evaluated three sequential treatment groups, or cohorts. Cohort ...
(Date:4/18/2017)... -- Research and Markets has announced the addition of ... offering. ... market to grow at a CAGR of 6.35% during the period ... has been prepared based on an in-depth market analysis with inputs ... growth prospects over the coming years. The report also includes a ...
(Date:4/18/2017)... 2017  Spero Therapeutics, LLC, a biopharmaceutical company founded ... infections, will present preclinical data supporting the use of ... (MDR) Gram-negative infections at the 27th European Congress of ... in Vienna, Austria . ... "Our ongoing preclinical ...
Breaking Medicine Technology:
(Date:4/21/2017)... ... April 21, 2017 , ... Brady (NYSE:BRC), a ... B-595 and B-7569 vinyl label materials received certification for the ... are tested to remain intact and legible, for use on chemical drums shipped by ...
(Date:4/21/2017)... , ... April 21, 2017 , ... The adage “Show, ... House, the next project in the company’s esteemed VISION House demonstration project series. Manifesting ... exactly the amount of resources they need to live affordably and abundantly without unduly ...
(Date:4/21/2017)... (PRWEB) , ... April 21, 2017 , ... The Hong ... the first 3D printing facility among higher education institutions in Hong Kong to support ... in terms of the range and quantity of facilities in Hong Kong. , ...
(Date:4/21/2017)... ... 2017 , ... Alive for Wellness is a group of clinical ... struggles. The Alive team uses advanced behavioral sciences treatment modalities to accomplish their ... mental health struggle is based on 10 modalities of treatment that include: ...
(Date:4/21/2017)... ... April 21, 2017 , ... Metrasens is honoured to ... the UK’s most prestigious award for business success. The company has been ... and has grown by a total of 400% over the last six years. ...
Breaking Medicine News(10 mins):